Risk factors associated with progression of diabetic retinopathy in eyes treated with panretinal photocoagulation

被引:4
|
作者
Baek, Sung Uk [1 ]
Park, Min Seon [1 ]
Cho, Bum-Joo [1 ]
Park, In Won [1 ]
Kwon, Soonil [1 ]
机构
[1] Hallym Univ, Coll Med, Sacred Heart Hosp, Dept Ophthalmol, 22 Gwanpyeong Ro,170beon Gil, Anyang 14068, South Korea
基金
新加坡国家研究基金会;
关键词
MEAN PLATELET VOLUME; RANIBIZUMAB; METAANALYSIS; SEVERITY; THERAPY; MARKER;
D O I
10.1038/s41598-021-93384-5
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Uncontrolled diabetes has been associated with progression of diabetic retinopathy (DR) in several studies. Therefore, we aimed to investigate systemic and ophthalmic factors related to worsening of DR even after completion of panretinal photocoagulation (PRP). We retrospectively reviewed DR patients who had completed PRP in at least one eye with a 3-year follow-up. A total of 243 eyes of 243 subjects (mean age 52.6 +/- 11.6 years) were enrolled. Among them, 52 patients (21.4%) showed progression of DR after PRP (progression group), and the other 191 (78.6%) patients had stable DR (non-progression group). The progression group had higher proportion of proliferative DR (P=0.019); lower baseline visual acuity (P<0.001); and higher platelet count (P=0.048), hemoglobin (P=0.044), and hematocrit, (P=0.042) than the non-progression group. In the multivariate logistic regression analysis for progression of DR, baseline visual acuity (HR: 0.053, P<0.001) and platelet count (HR: 1.215, P=0.031) were identified as risk factors for progression. Consequently, we propose that patients with low visual acuity or high platelet count are more likely to have progressive DR despite PRP and require careful observation. Also, the evaluation of hemorheological factors including platelet counts before PRP can be considered useful in predicting the prognosis of DR.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Panretinal Photocoagulation Plus Intravitreal Bevacizumab Versus Panretinal Photocoagulation Alone for Proliferative Diabetic Retinopathy
    Ali, Warda
    Abbasi, Kanwal Zareen
    Raza, Ali
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2018, 28 (12): : 923 - 927
  • [2] Panretinal photocoagulation versus panretinal photocoagulation plus intravitreal bevacizumab for high-risk proliferative diabetic retinopathy
    Zhou, Ai-Yi
    Zhou, Chen-Jing
    Yao, Jing
    Quan, Yan-Long
    Ren, Bai-Chao
    Wang, Jian-Ming
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2016, 9 (12) : 1772 - 1778
  • [3] Panretinal Photocoagulation for Diabetic Retinopathy in the RIDE and RISE Trials Not "1 and Done"
    Gonzalez, Victor H.
    Wang, Pin-Wen
    Ruiz, Carlos Quezada
    OPHTHALMOLOGY, 2021, 128 (10) : 1448 - 1457
  • [4] A comparison between the therapeutic effects of Conbercept combined with panretinal photocoagulation and panretinal photocoagulation monotherapy for high-risk proliferative diabetic retinopathy
    Sun, Yaoyao
    Qi, Huijun
    FRONTIERS IN ENDOCRINOLOGY, 2023, 13
  • [5] The Effectiveness of Conbercept Combined with Panretinal Photocoagulation vs. Panretinal Photocoagulation in the Treatment of Diabetic Retinopathy: A Meta-Analysis
    Huang, Chao
    Ji, Haiqing
    Han, Xuguang
    JOURNAL OF OPHTHALMOLOGY, 2021, 2021
  • [6] Intravitreal conbercept injection with panretinal photocoagulation for high-risk proliferative diabetic retinopathy with vitreous hemorrhage
    Xu, Yao
    Ye, Qing
    Shen, Wei
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2024, 17 (06) : 1066 - 1072
  • [7] Evaluation of contrast sensitivity in non-high-risk proliferative diabetic retinopathy treated with panretinal photocoagulation with and without intravitreal injections of ranibizumab
    Rentiya, Zubir S.
    Ferraz, Daniel A.
    Hutnik, Robert
    Bae, Junun
    Machado, Cleide G.
    Mucciolli, Cristina
    da Motta, Augusto Alves L.
    Ribeiro, Lucas Z.
    Guan, Zeyu
    Preti, Rony Carlos
    Takahashi, Walter Y.
    ARQUIVOS BRASILEIROS DE OFTALMOLOGIA, 2022, 85 (01) : 37 - 45
  • [8] A RANDOMIZED CONTROLLED TRIAL OF PANRETINAL PHOTOCOAGULATION WITH AND WITHOUT INTRAVITREAL RANIBIZUMAB IN TREATMENT-NAIVE EYES WITH NON-HIGH-RISK PROLIFERATIVE DIABETIC RETINOPATHY
    Ferraz, Daniel A.
    Vasquez, Lisa M.
    Preti, Rony C.
    Motta, Augusto
    Sophie, Raafay
    Bittencourt, Millena G.
    Sepah, Yasir J.
    Monteiro, Mario L. R.
    Quan Dong Nguyen
    Takahashi, Walter Yukihiko
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (02): : 280 - 287
  • [9] Longitudinal neovascular changes on optical coherence tomography angiography in proliferative diabetic retinopathy treated with panretinal photocoagulation alone versus with intravitreal conbercept plus panretinal photocoagulation: a pilot study
    He, Feng
    Yu, Weihong
    EYE, 2020, 34 (08) : 1413 - 1418
  • [10] Anti-VEGF Pharmacotherapy as an Alternative to Panretinal Laser Photocoagulation for Proliferative Diabetic Retinopathy
    Olsen, Timothy W.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (20): : 2135 - 2136